Growth momentum ProofPilot has recent funding and strategic acquisitions, including a $7.7M raise and the Lokavant acquisition, indicating strong growth traction and potential for upsell to existing customers or cross-sell of expanded clinical analytics capabilities.

End-to-end platform As a leading end-to-end Clinical Experience Platform, ProofPilot presents opportunities to upsell integration services with patient experience optimization, trial recruitment enhancements, and site operations simplification for mid to large CROs and sponsors.

Executive leadership New leadership appointments such as a VP of Clinical Strategy & Solutions and a Chief Customer Officer signal a focus on strategic partnerships and customer success, suggesting a doorway for expanded account management and executive sponsorship conversations.

Global events Active participation in industry events like SCOPE 2025 and CORE Symposium launch offer venues for targeted outreach, partnerships, and pilot programs with clinical operations teams seeking cutting-edge recruitment and engagement solutions.

Financial health Revenue range and established funding position suggest a stable financial footing, enabling conversations around longer-term contracts, multi-site deployments, and renewal opportunities with enterprise customers seeking scalable trial management solutions.